Key Points
- To determine whether TBX20-associated cardiac pathology arises during embryonic development or stems from an ongoing requirement for the gene in adult cardiomyocytes.
- Generated an adult cardiomyocyte-specific conditional Tbx20 ablation mouse model.
- Performed genome-wide chromatin immunoprecipitation (ChIP) analysis to identify direct Tbx20-binding targets and novel DNA-binding sites in adult heart tissue.
- Conducted bioinformatics and in vivo functional analyses to evaluate gene expression changes and transcription factor networks.
- Loss of Tbx20 in adult cardiomyocytes caused rapid onset of severe cardiomyopathy and lethal arrhythmias, resulting in death within 1 to 2 weeks.
- Ablation led to substantial downregulation of critical transcription factors, ion channel genes, and cytoskeletal/myofibrillar structural proteins.
- Genome-wide ChIP and bioinformatics revealed a previously undescribed Tbx20 DNA-binding site and demonstrated that Tbx20 collaborates with a transcription factor cohort to maintain ion channel expression.
Structured PICO
PPopulationAdult mice (model for Tbx20 ablation in adult cardiomyocytes)
IInterventionAblation of Tbx20 specifically in adult cardiomyocytes
OOutcomeOnset of severe cardiomyopathy, arrhythmias, and death
Tbx20 is a central integrator of a genetic program essential for maintaining adult cardiomyocyte function, and its loss rapidly induces fatal cardiomyopathy and arrhythmias.